3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...

Recent advances in portable and automated molecular diagnostic systems will address the previously unmet need for decentralized, point-of-care nucleic acid testing. Rapid, accurate diagnostic systems ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

To help patients get tested and treated for the flu, healthcare providers should embrace point-of-care molecular testing — a faster, more accurate diagnostic method, Norman Moore, PhD, director of ...

The point of care molecular diagnostics market is experiencing steady growth, with a CAGR of ~6% driven by increasing demand for rapid and decentralized diagnostic solutions. Key factors propelling ...

The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...

Hypnotizability testing requires special training and in-person evaluation rarely available in the clinical setting. Now, investigators have developed a fast, point-of-care molecular diagnostic test ...

DELRAY BEACH, Fla., Sept. 3, 2025 /PRNewswire/ -- The global Point-of-Care Molecular Diagnostics Market, valued at US$4.01 billion in 2024, stood at US$4.30 billion in 2025 and is projected to advance ...

Powered by Money.com - Yahoo may earn commission from the links above. By end user, the point-of-care molecular diagnostics market, by end user, is segmented into physicians' offices/clinics, ...